PET in the aging brain. ([2010])
- Record Type:
- Book
- Title:
- PET in the aging brain. ([2010])
- Main Title:
- PET in the aging brain
- Further Information:
- Note: Guest editors, Andrew B. Newberg, Abass Alavi.
- Editors:
- Newberg, Andrew B, 1966-
Alavi, Abass - Contents:
- Front Cover; Contributors; Contents; PET Clinics; Preface; Chapter 1. Normal Patterns and Variants in PET Brain Imaging; NORMAL VARIANTS IN FUNCTIONAL NEUROIMAGING STUDIES; NEUROIMAGING IN THE STUDY OF NORMAL AGING FROM INFANCY TO ADULTHOOD; NEUROTRANSMITTER FUNCTION IN NORMAL AGING; OTHER BIOCHEMICAL CHANGES IN NORMAL AGING; SUMMARY; REFERENCES; Chapter 2. Evaluation of Early Dementia (Mild Cognitive Impairment); FDG-PET STUDIES; ''AT RISK'' POPULATIONS; AMYLOID PET IMAGING; PIB; FDDNP; COMPARATIVE STUDIES; LIMITATIONS; SUMMARY; REFERENCES; Chapter 3. Amyloid PET Ligands for Dementia. ALZHEIMER'S DISEASE AND OTHER DEMENTIASAMYLOID LIGANDS; AMYLOID IMAGING IN DEMENTIA; AMYLOID IMAGING AND OTHER MARKERS OF DISEASE; SPECIFIC BIOMARKERS OF DISEASE; SUMMARY; REFERENCES; Chapter 4. 18F-Fluorodeoxyglucose PET in the Evaluation of Parkinson Disease; METABOLIC NETWORKS IN PARKINSONISM; METABOLIC PATTERNS IN ATYPICAL PARKINSONIAN SYNDROMES; DIFFERENTIAL DIAGNOSIS USING PET; CHANGES IN NETWORK ACTIVITY WITH DISEASE PROGRESSION IN PD; NETWORK MODULATION WITH PD THERAPY; SUMMARY; ACKNOWLEDGMENTS; REFERENCES; Chapter 5. SPECT and PET in Atypical Parkinsonism. THE SPECTRUM OF MOVEMENT DISORDERSDOPAMINERGIC IMAGING IN THE DIAGNOSIS OF PARKINSONISM AND RELATED DISORDERS; NONDOPAMINERGIC IMAGING IN THE DIFFERENTIAL DIAGNOSIS OF MOVEMENT DISORDERS; IDENTIFYING NEW TARGETS AND IMAGING BIOMARKERS IN PARKINSON SPECTRUM DISORDERS; SUMMARY; REFERENCES; Chapter 6. 18F-AV-133: A SelectiveFront Cover; Contributors; Contents; PET Clinics; Preface; Chapter 1. Normal Patterns and Variants in PET Brain Imaging; NORMAL VARIANTS IN FUNCTIONAL NEUROIMAGING STUDIES; NEUROIMAGING IN THE STUDY OF NORMAL AGING FROM INFANCY TO ADULTHOOD; NEUROTRANSMITTER FUNCTION IN NORMAL AGING; OTHER BIOCHEMICAL CHANGES IN NORMAL AGING; SUMMARY; REFERENCES; Chapter 2. Evaluation of Early Dementia (Mild Cognitive Impairment); FDG-PET STUDIES; ''AT RISK'' POPULATIONS; AMYLOID PET IMAGING; PIB; FDDNP; COMPARATIVE STUDIES; LIMITATIONS; SUMMARY; REFERENCES; Chapter 3. Amyloid PET Ligands for Dementia. ALZHEIMER'S DISEASE AND OTHER DEMENTIASAMYLOID LIGANDS; AMYLOID IMAGING IN DEMENTIA; AMYLOID IMAGING AND OTHER MARKERS OF DISEASE; SPECIFIC BIOMARKERS OF DISEASE; SUMMARY; REFERENCES; Chapter 4. 18F-Fluorodeoxyglucose PET in the Evaluation of Parkinson Disease; METABOLIC NETWORKS IN PARKINSONISM; METABOLIC PATTERNS IN ATYPICAL PARKINSONIAN SYNDROMES; DIFFERENTIAL DIAGNOSIS USING PET; CHANGES IN NETWORK ACTIVITY WITH DISEASE PROGRESSION IN PD; NETWORK MODULATION WITH PD THERAPY; SUMMARY; ACKNOWLEDGMENTS; REFERENCES; Chapter 5. SPECT and PET in Atypical Parkinsonism. THE SPECTRUM OF MOVEMENT DISORDERSDOPAMINERGIC IMAGING IN THE DIAGNOSIS OF PARKINSONISM AND RELATED DISORDERS; NONDOPAMINERGIC IMAGING IN THE DIFFERENTIAL DIAGNOSIS OF MOVEMENT DISORDERS; IDENTIFYING NEW TARGETS AND IMAGING BIOMARKERS IN PARKINSON SPECTRUM DISORDERS; SUMMARY; REFERENCES; Chapter 6. 18F-AV-133: A Selective VMAT2-binding Radiopharmaceutical for PET Imaging of Dopaminergic Neurons; APPROACHES TO DA NEURON IMAGING; VMAT2 AS PET IMAGING TARGET; REFERENCES; Chapter 7. PET in Cerebrovascular Disease; NORMAL CEREBRAL HEMODYNAMICS AND ENERGY METABOLISM; CEREBROVASCULAR CONTROL. HEMODYNAMIC EFFECTS OF ARTERIAL OCCLUSIVE DISEASEEVOLUTION OF ACUTE INFARCTION; IDENTIFICATION OF PREVENTABLE INFARCTION; CAROTID ARTERY ATHEROSCLEROSIS; REMOTE METABOLIC EFFECTS OF CEREBRAL INFARCTION; VASCULAR DEMENTIA; INTRACEREBRAL HEMORRHAGE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; SUMMARY; REFERENCES; Chapter 8. Imaging Pathophysiology and Neuroplasticity After Stroke; CEREBROVASCULAR DISEASE; EVALUATION OF CBF, METABOLISM, AND RECEPTORS USING PET TRACERS; METABOLISM, OEF, AND CEREBROVASCULAR REACTIVITY MEASUREMENTS OF PERIINFARCTION TISSUE HEMODYNAMICS; EVALUATION OF ISCHEMIA BY PET. Pet measures of cbf and oeftime-dependent progressively evolving stroke penumbra; pet measures of cerebral tissue viability status in ischemic brain; recovery from stroke: diaschisis resolution and cerebral reorganization; cerebral diaschisis as a result of stroke; improvement of stroke-induced neurologic deficits attributable to cerebral diaschisis resolution; cerebral reorganization; improvement of stroke-induced neurologic deficits attributable to cerebral reorganization; adaptive plasticity in stroke recovery. … (more)
- Publisher Details:
- Philadelphia : Saunders
- Publication Date:
- 2010
- Extent:
- 1 online resource, color illustrations
- Subjects:
- 618.976890757
Tomography, Emission
Brain -- Imaging
Brain -- Diseases -- Diagnosis
Alzheimer's disease -- Imaging
Brain -- Aging
MEDICAL -- Gynecology & Obstetrics
Electronic books - Languages:
- English
- ISBNs:
- 9781455700554
- Related ISBNs:
- 145570055X
9781437719413
1437719414 - Notes:
- Note: Includes bibliographical references and index.
Note: Online resource; title from PDF title page (EBSCO, viewed January 28, 2016). - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.240726
- Ingest File:
- 01_157.xml